Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.

Biochemistry, Genetics and Molecular Biology

• Hypertriglyceridemia 100%
• Triglyceride-Rich Lipoprotein 100%
• Diacylglycerol 66%
• Mutation 33%
• Oligonucleotide 33%
• Catabolism 33%
• Oxidative Stress 33%
• Insulin Resistance 33%
• Dyslipidemia 33%
• Low-Density Lipoprotein 33%
• Microsomal Triglyceride Transfer Protein 33%
• Apolipoprotein B 33%
• Acyltransferase 33%
• Lifestyle 33%
• Niacin 33%
• Receptor Agonists 33%
• Exercise 33%
• Incretin 33%
• Antisense 33%
• Lipid 33%
• Weight 33%
• Lipoprotein Metabolism 33%
• Omega 3 Fatty Acid 33%
• Apolipoprotein C 33%
• Fibrate 33%